These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Controlled evaluation of bendroflumethiazide in the treatment of essential hypertension. Spitzer TQ; Harris BA Curr Ther Res Clin Exp; 1975 Jan; 17(1):75-9. PubMed ID: 806431 [No Abstract] [Full Text] [Related]
23. A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol. Zacharias FJ Postgrad Med J; 1981; 57 Suppl 2():51-2. PubMed ID: 7033947 [TBL] [Abstract][Full Text] [Related]
24. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension]. Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448 [No Abstract] [Full Text] [Related]
25. [Results of a study with the antihypertensive agent Torrat]. Werning C Ther Ggw; 1978 Dec; 117(12):1924-9. PubMed ID: 31703 [No Abstract] [Full Text] [Related]
26. Advantages and benefits of once-daily nadolol treatment in hypertension. González D J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507 [TBL] [Abstract][Full Text] [Related]
28. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation. Jackson DA Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120 [No Abstract] [Full Text] [Related]
29. Effects of antihypertensive agents on blood velocity: implications for atherogenesis. Spence JD Can Med Assoc J; 1982 Oct; 127(8):721-4. PubMed ID: 7139486 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of hypotensive effect of nadolol]. Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065 [No Abstract] [Full Text] [Related]
31. Clinical evaluation of Declinax in Nigerian hypertensives. Cole TO; Adadevoh BK Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743 [No Abstract] [Full Text] [Related]
32. [Comparative assessment of the results of new antihypertensive drugs]. Schubert R; Pasz T; Lindner O Munch Med Wochenschr; 1968 Jul; 110(27):1604-9. PubMed ID: 5756285 [No Abstract] [Full Text] [Related]
33. [Dose-response study of betaxolol in arterial hypertension]. Pathe M; Steimer C; Cazor JL; Schwartz J Therapie; 1983; 38(2):143-8. PubMed ID: 6356451 [No Abstract] [Full Text] [Related]
34. Timolol and bendroflumethiazide in the treatment of hypertension. Karatzas NB; Papazachos G; Clouva P; Tsaknakis T J Int Med Res; 1979; 7(3):215-20. PubMed ID: 378730 [No Abstract] [Full Text] [Related]
35. Hydrochlorothiazide and nadolol in the treatment of hypertension. Olerud B Practitioner; 1982 Apr; 226(1366):785-7. PubMed ID: 7045854 [No Abstract] [Full Text] [Related]
36. [Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson]. Grajek S; Szymczyńska A; Urbański K; Lehman Z; Kozłowska F; Paradowski S; Gracz M Kardiol Pol; 1986; 29(7):440-53. PubMed ID: 2879953 [No Abstract] [Full Text] [Related]
37. [Treating essential hypertension. Are beta blockers still first choice?]. Rahn KH MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414 [No Abstract] [Full Text] [Related]
39. Double-blind comparison of Inderal LA (160 mg), Half-Inderal LA (80 mg), and Half-Inderal LA plus bendrofluazide (2.5 mg) in the treatment of elderly hypertensive patients. Agrawal RL Br J Clin Pract; 1987 Sep; 41(9):916-20. PubMed ID: 3330455 [No Abstract] [Full Text] [Related]
40. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)]. G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]